About
Our Mission
Veana is a clinical stage company dedicated to developing innovative oral medicines for the treatment of cancer. Our medicines are designed to selectively target and destroy the energy powerhouse (mitochondria) of cancer cells in a fashion that subsequently stimulates the anti-tumor immune response.
Technologies
Veana’s mitochondria inhibition technology consists of oral medicines that preferentially attack the mitochondria (energy powerhouses) of cancer cells to destroy them by two processes known as apoptosis and autophagy. Dying by autophagy results in the production of cancer antigen-containing vesicles known as “autophagosomes”. These autophagosomes are taken up by immune cells known as dendritic cells, which process the cancer antigens and ”show” them to a unique population of immune cells known as T lymphocytes, which then are stimulated to recognize and destroy more cancer cells.
“Veana Therapeutics’ mission is to develop effective and safer oral cancer medicines that will improve and extend the lives of the many people who are affected by the deadly disease of cancer”
